RAPISAFE

Serial Number 79332919
Registration 7109718
700

Registration Progress

Application Filed
Dec 14, 2021
Under Examination
Approved for Publication
May 2, 2023
Published for Opposition
May 2, 2023
Registered
Jul 18, 2023

Trademark Image

RAPISAFE

Basic Information

Serial Number
79332919
Registration Number
7109718
Filing Date
December 14, 2021
Registration Date
July 18, 2023
Published for Opposition
May 2, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 18, 2023
Registration
Registered
Classes
005

Rights Holder

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

99
Address
21st Floor, Snibe Building,
CN

Ownership History

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

Original Applicant
99
CN

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

Owner at Publication
99
CN

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

Original Registrant
99
CN

Legal Representation

Attorney
Stacy L. Emhoff

USPTO Deadlines

Next Deadline
1446 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-07-18)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Dec 18, 2023 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Oct 18, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Oct 18, 2023 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Oct 18, 2023 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Jul 31, 2023 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jul 18, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jul 18, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 12, 2023 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 12, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 2, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 2, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 1, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Apr 12, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 12, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Apr 12, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Mar 30, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 30, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 30, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 30, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2023 RFNP P REFUSAL PROCESSED BY IB Loading...
Dec 9, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 8, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 28, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 21, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 15, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 11, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 10, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the functional analysis of blood coagulation and fibrinolysis; Pharmaceutical preparations for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemico-pharmaceutical preparations for pharmaceutical purposes, namely, chemico-pharmaceutical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemico-pharmaceutical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Medicated serums used for the functional analysis of blood coagulation and fibrinolysis; Medicated serums used for the quantitative and qualitative detection of analytes in human serum, plasma and body fluids; Medicines for serum therapy, namely, medicines for serum therapy for functional analysis of blood coagulation and fibrinolysis; Medicines for serum therapy for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Biological preparations for medical purposes, namely, biological preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; Biological preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; Chemical preparations for pharmaceutical purposes, namely, chemical preparations for pharmaceutical purposes for the functional analysis of blood coagulation and fibrinolysis; Chemical preparations for pharmaceutical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; chemical preparations for medical purposes, namely, chemical preparations for medical purposes for the functional analysis of blood coagulation and fibrinolysis; chemical preparations for medical purposes for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; enzymes for medical purposes; enzyme preparations for medical purposes; Preparations for pharmaceutical purposes, namely, preparations for pharmaceutical purposes made of trace elements that are found in the human body for the functional analysis of blood coagulation and fibrinolysis; Preparations for pharmaceutical purposes made of trace elements that are found in the human body for the quantitative and qualitative detection of substances in human serum, plasma and body fluids; amino acids for medical purposes; preparations of microorganisms for medical or veterinary use; chemical preparations for the diagnosis of pregnancy; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; veterinary preparations for treatment of intestinal bacteria; medicines for veterinary purposes for treatment of intestinal bacteria; biological preparations for veterinary purposes for treatment of intestinal bacteria; chemical preparations for veterinary purposes for treatment of intestinal bacteria; enzymes for veterinary purposes; enzyme preparations for veterinary purposes; diagnostic preparations for veterinary purposes; reagent paper for veterinary purposes
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005